专题论文

原位辅助性部分肝移植

  • 陈琳 ,
  • 陈孝平
展开
  • 华中科技大学同济医学院附属同济医院肝脏外科中心, 武汉 430030
陈琳,主治医师,医学博士,研究方向为肝胆胰疾病的外科治疗、脏干细胞与肝再生、肝癌复发转移的分子机制等,电子信箱:chenlin_tj@126.com

收稿日期: 2016-09-20

  修回日期: 2016-10-14

  网络出版日期: 2016-11-05

Auxiliary partial orthotopic liver transplantation

  • CHEN Lin ,
  • CHEN Xiaoping
Expand
  • Hepatic Surgery Centre, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, China

Received date: 2016-09-20

  Revised date: 2016-10-14

  Online published: 2016-11-05

摘要

自1989年原位辅助性部分肝移植成功应用于临床治疗急性肝功能衰竭以来,适应证逐渐扩大至肝功能衰竭、遗传代谢疾病、终末期肝硬化。随技术不断进步趋于成熟,并发症发生率显著降低,远期存活率明显上升,对部分疾病治疗效果达到甚至优于原位肝移植术,并衍生出多米诺原位辅助性部分肝移植等新术式,显著拓展了供体来源及受益人群,成为肝脏疾病重要的治疗手段。本文介绍原位辅助性部分肝移植术的发展历程及研究进展。

本文引用格式

陈琳 , 陈孝平 . 原位辅助性部分肝移植[J]. 科技导报, 2016 , 34(20) : 40 -44 . DOI: 10.3981/j.issn.1000-7857.2016.20.006

Abstract

Since the auxiliary partial orthotopic liver transplantation (APOLT) was successfully applied as a clinical treatment for the acute liver failure in 1989, the indication of APOLT has been gradually expanded to the liver failure, the metabolic liver disease and the endstage liver cirrhosis. With the surgical technique gradually coming to a mature stage, the postoperative complication rate is significantly reduced and the long-term survival outcome sees an encouraging up-trend. In selected patients such as those of acute liver failure, APOLT even offers an advantage over the orthotopic liver transplantation, which was regard as the standard for these diseases. The emergence of new types of APOLT such as the Domino APOLT and the Cross-Domino APOLT will significantly expand the donor source and the beneficiaries. The APOLT has become an important treatment of liver diseases.

参考文献

[1] Chen X P. An experimental study of auxiliary partial liver allotransplantation in dogs[J]. Journal of Tongji Medical University, 1987, 7:15-20.
[2] Gubernatis G, Pichlmayr R, Kemnitz J, et al. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure:first successful case report[J]. World Journal of Surgery, 1991, 15(5):660-665.
[3] 骆明德, 余业勤, 汤钊猷. 大鼠原位辅助性部分肝移植[J]. 中华外科杂志, 1997, 35(9):50-52.
[4] 肖卫东, 吴伟顶, 彭承宏, 等. 辅助性部分原位肝移植治疗暴发性肝功能衰竭的实验研究现状[J]. 中华肝胆外科杂志, 2004, 10(5):73-75.
[5] 彭承宏, 史留斌, 彭淑牖, 等. 新辅助性原位部分肝移植动物模型的建立[J]. 中华医学杂志, 2002, 82(15):49-51.
[6] 程琪, 高丹, 龙新, 等. 小鼠辅助性原位部分肝移植模型的建立[J]. 中华器官移植杂志, 2014, 35(9):552-554.
[7] Cheng Q, He S Q, Gao D, et al. Early application of auxiliary partial orthotopic liver transplantation in murine model of wilson isease[J]. Transplantation, 2015, 99(11):2317-2324.
[8] 窦科峰, 管文贤, 李开宗, 等. 辅助性原位活体肝部分移植一例报告[J]. 中华普通外科杂志, 2002, 17(4):197-199.
[9] 刘正才, 窦科峰, 管文贤, 等. 不同术式活体肝移植长期生存随访2例[J]. 第四军医大学学报, 2006, 27(15):1410-1410.
[10] 王学浩, 张峰, 李相成, 等. 亲属活体部分肝移植治疗肝豆状核变性的临床研究[J]. 中华医学杂志, 2006, 86(46):3290-3293.
[11] 周光文, 彭承宏, 沈柏用, 等. 辅助性原位尸肝部分移植治疗Wilson病的疗效初探[J]. 外科理论与实践, 2004, 9(11):54-56.
[12] Zhu J, Xia Q, Zhang J, et al. Living donor auxiliary partial orthotopic liver transplantation for acute liver failure:A case report[J]. Hepatogastroenterology, 2014, 61(131):792-794.
[13] Duan W D, Wang X T, Wang H G, et al. Auxiliary partial liver transplantation for acute liver failure using "high risk" grafts:Case report[J]. World Journal of Gastroenterology, 2016, 22(5):1919-1924.
[14] Boudjema K, Jaeck D, Simeoni U, et al. Temporary auxiliary liver transplantation for subacute liver failure in a child[J]. The Lancet, 1993, 342(8874):778-779.
[15] van Hoek B, de Boer J, Boudjema K, et al. Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT study group. European auxiliary liver transplant registry[J]. Journal of Hepatology, 1999, 30(4):699-705.
[16] Faraj W, Dar F, Bartlett A, et al. Auxiliary liver transplantation for acute liver failure in children[J]. Annals of Surgery, 2010, 251(2):351-356.
[17] Asonuma K, Gilbert J C, Stein J E, et al. Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia[J]. Journal of Pediatric Surgery, 1992, 27(3):298-301.
[18] Whitington P F, Emond J C, Heffron T, et al. Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1[J]. The Lancet, 1993, 342(8874):779-780.
[19] Kim B S, Joo S H, Lee S H, et al. Auxiliary partial orthotopic liver transplantation for adult onset type Ⅱ citrullinemia[J]. Journal of The Korean Surgical Society, 2011, 80(Suppl 1):51-54.
[20] Ohno Y, Mita A, Ikegami T, et al. Temporary auxiliary partial orthotopic liver transplantation using a small graft for familial amyloid polyneuropathy[J]. American Journal of Transplantation, 2012, 12(8):2211-2219.
[21] Jaeck D, Pessaux P, Wolf P. Which types of graft to use in patients with acute liver failure? (A) Auxiliary liver transplant (B) Living donor liver transplantation (C) The whole liver. (A) I prefer auxiliary liver transplant[J]. Journal of Hepatology, 2007, 46(4):570-573.
[22] Rajput I, Prasad K R, Bellamy M C, et al. Subtotal hepatectomy and whole graft auxiliary transplantation for acetaminophen-associated acute liver failure[J]. HPB (Oxford), 2014, 16(3):220-228.
[23] Kasahara M, Takada Y, Kozaki K, et al. Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease[J]. Journal of Pediatric Surgery, 2004, 39(7):1138-1141.
[24] Kasahara M, Takada Y, Egawa H, et al. Auxiliary partial orthotopic living donor liver transplantation:Kyoto University experience[J]. American Journal of Transplantation, 2005, 5(3):558-565.
[25] Rela M, Bharathan A, Palaniappan K, et al. Portal flow modulation in auxiliary partial orthotopic liver transplantation[J]. Pediatric Transplantation, 2015, 19(3):255-260.
[26] Shanmugam N P, Perumalla R, Gopinath R, et al. Auxiliary liver transplantation:A form of gene therapy in selective metabolic disorders[J]. Journal of Clinical and Experimental Hepatology, 2011, 1(2):118-120.
[27] Broering D C, Walter J, Bassas A F. Overcoming the portal steal phenomenon in auxiliary partial orthotopic liver transplantation by modulation of the venous outflow of the native liver[J]. Liver Transplantation, 2005, 11(9):1140-1143.
[28] Marques H P, Ribeiro V, Almeida T, et al. Long-term results of domino liver transplantation for hepatocellular carcinoma using the "Double Piggyback" technique:A 13-year experience[J]. Annals of Surgery, 2015, 262(5):749-756.
[29] Govil S, Shanmugam N P, Reddy M S, et al. A metabolic chimera:Two defective genotypes make a normal phenotype[J]. Liver Transplantation, 2015, 21:1453-1454.
文章导航

/